Chronic catastrophes: Exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada

Social Science and Medicine

Volumn 68, Issue 5, 2009, Pages 919-924

  Hanley, Gillian E ^a   Morgan, Steve ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

British Columbia; Canada; Cost inequalities; High cost pharmaceutical use; Pharmaceutical policy; Prescription drugs

Indexed keywords

CATASTROPHIC EVENT; CONCENTRATION (COMPOSITION); DRUG; HEALTH EXPENDITURE; HEALTH POLICY; HOSPITAL SECTOR; SOCIOECONOMIC STATUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANALYSIS OF VARIANCE; BRITISH COLUMBIA; CANADA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DATABASES, FACTUAL; DRUG COSTS; DRUG UTILIZATION; FEMALE; HEALTH STATUS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PRESCRIPTION DRUGS; SOCIOECONOMIC FACTORS; UNIVERSAL COVERAGE; YOUNG ADULT;

BRITISH COLUMBIA; CANADA; NORTH AMERICA;

EID: 60349130277     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2008.12.008     Document Type: Article

References (21)

1. Anderson G., and Knickman J.R. Patterns of expenditures among high utilizers of medical care services: the experience of Medicare beneficiaries from 1974 to 1977. Medical Care 22 (1984) 143-149
2. Arrow K.J. Uncertainty and the welfare economics of medical care. Journal of Health Politics Policy and Law 26 (2001) 851-883
3. Berki S.E., Lepkowski J.N., Wyszewianski L., Landis J.R., Magilavy M.L., McLaughlin C.G., et al. High-volume and low-volume users of health services: United States, 1980. National Medical Care Utilization & Expenditure Survey - Series C 2 (1985) 1-88
4. Densen P.M., Shapiro S., and Einhorn M. Concerning high and low utilizers of service in a medical care plan, and the persistence of utilization levels over a three year period. Milbank Memorial Fund Quarterly 37 (1959) 217-250
5. Hurley J. An overview of the normative economics of the health sector. In: Culyer A.J., and Newhouse J.P. (Eds). Handbook of health economics (2000), Elsevier Science, Amsterdam 55-118
6. Kozyrskyj A., Lix L., Dahl M., and Soodeen R.-A. High-cost users of pharmaceuticals: Who are they? (2005), Manitoba Centre for Health Policy, Winnipeg, Manitoba
7. Mallya G., and Bazemore A. Medicare Part D: practical and policy implications for family physicians. American Family Physician 73 (2006) 395-396
8. NPS, Federal/Provincial/Territorial Ministerial Task Force on the National Pharmaceuticals Strategy. National pharmaceuticals strategy progress report (2006), Health Canada, Ottawa, Ontario
9. Organisation for Economic Co-operation and Development. OECD health data 2006 (2006) [CD-ROM]
10. Reid R., Evans R., Barer M., Sheps S., Kerluke K., McGrail K., et al. Conspicuous consumption: characterizing high users of physician services in one Canadian province. Journal of Health Services Research and Policy 8 (2003) 215-224
11. Reid R., MacWilliam L., Roos N., Bogdanovich B., and Black C. Measuring morbidity in populations: Performance of the Johns Hopkins Adjusted Clinical Group case-mix adjustment system in Manitoba (1999), Manitoba Centre for Health Policy, Winnipeg, Manitoba
12. Reid R.J., MacWilliam L., Verhulst L., Roos N., and Atkinson M. Performance of the ACG case-mix system in two Canadian provinces. Medical Care 39 (2001) 86-99
13. Reid R.J., Roos N.P., MacWilliam L., Frohlich N., and Black C. Assessing population health care need using a claims-based ACG morbidity measure: a validation analysis in the province of Manitoba. Health Services Research 37 (2002) 1345-1364
14. Shapiro S.H., Wilson G., Griffith F., and Oseasohn R. Long-term adult use of ambulatory services provided by physicians in a Canadian medical care plan. Medical Care 24 (1986) 418-428
15. Shepperd S., and Iliffe S. Hospital at home versus in-patient hospital care. Cochrane Database of Systematic Review 3 (2005) 356-385
16. Stuart B., Simoni-Wastila L., and Chauncey D. Assessing the impact of coverage gaps in the Medicare Part D drug benefit. Health Affairs (Millwood) (2005) Suppl Web Exclusives, W5-167-W165-179
17. United States of America. (2004). Medicare prescription drug, improvement, and modernization act of 2003.
18. Wagstaff A., van Doorslaer E., Calonge S., Christiansen T., Gerfin M., Gottschalk P., et al. Equity in the finance of health care: some international comparisons. Journal of Health Economics 11 (1992) 361-387
19. Wagstaff A., van Doorslaer E., van der Burg H., Calonge S., Christiansen T., Citoni G., et al. Equity in the finance of health care: some further international comparisons. Journal of Health Economics 18 (1999) 263-290
20. World Health Organization. Guidelines for ATC classification and DDD assignment 2004 (2004), WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway
21. Zook C.J., and Moore F.D. High-cost users of medical care. New England Journal of Medicine 302 (1980) 996-1002